Carregant...
An in-silico evaluation of COVID-19 main protease with clinically approved drugs
A novel strain of coronavirus, namely, SARS-CoV-2 identified in Wuhan city of China in December 2019, continues to spread at a rapid rate worldwide. There are no specific therapies available and investigations regarding the treatment of this disease are still lacking. In order to identify a novel po...
Guardat en:
| Publicat a: | J Mol Graph Model |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7503128/ https://ncbi.nlm.nih.gov/pubmed/33007575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmgm.2020.107758 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|